Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice.
Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice.
复制标题
戊糖片球菌 CECT 8330 保护 DSS 诱导的结肠炎并调节小鼠肠道微生物群和免疫反应
DOI:
10.1186/s12967-022-03235-8
复制
发表时间:
2022-01-15
影响因子:
7.4
通讯作者:
Wang Y
中科院分区:
文献类型:
--
作者:
Dong F;Xiao F;Li X;Li Y;Wang X;Yu G;Zhang T;Wang Y
Compelling evidences demonstrated that gut microbiota dysbiosis plays a critical role in the pathogenesis of inflammatory bowel diseases (IBD). Therapies for targeting the microbiota may provide alternative options for the treatment of IBD, such as probiotics. Here, we aimed to investigate the protective effect of a probiotic strain, Pediococcus pentosaceus (P. pentosaceus) CECT 8330, on dextran sulfate sodium (DSS)-induced colitis in mice. C57BL/6 mice were administered phosphate-buffered saline (PBS) or P. pentosaceus CECT 8330 (5 × 108 CFU/day) once daily by gavage for 5 days prior to or 2 days after colitis induction by DSS. Weight, fecal conditions, colon length and histopathological changes were examined. ELISA and flow cytometry were applied to determine the cytokines and regulatory T cells (Treg) ratio. Western blot was used to examine the tight junction proteins (TJP) in colonic tissues. Fecal short-chain fatty acids (SCFAs) levels and microbiota composition were analyzed by targeted metabolomics and 16S rRNA gene sequencing, respectively. The Kyoto Encyclopedia of Genes and Genomes (KEGG) and Cluster of orthologous groups of proteins (COG) pathway analysis were used to predict the microbial functional profiles. P. pentosaceus CECT 8330 treatment protected DSS-induced colitis in mice as evidenced by reducing the weight loss, disease activity index (DAI) score, histological damage, and colon length shortening. P. pentosaceus CECT 8330 decreased the serum levels of proinflammatory cytokines (TNF-α, IL-1β, and IL-6), and increased level of IL-10 in DSS treated mice. P. pentosaceus CECT 8330 upregulated the expression of ZO-1, Occludin and the ratio of Treg cells in colon tissue. P. pentosaceus CECT 8330 increased the fecal SCFAs level and relative abundances of several protective bacteria genera, including norank_f_Muribaculaceae, Lactobacillus, Bifidobacterium, and Dubosiella. Furthermore, the increased abundances of bacteria genera were positively correlated with IL-10 and SCFAs levels, and negatively associated with IL-6, IL-1β, and TNF-α, respectively. The KEGG and COG pathway analysis revealed that P. pentosaceus CECT 8330 could partially recover the metabolic pathways altered by DSS. P. pentosaceus CECT 8330 administration protects the DSS-induced colitis and modulates the gut microbial composition and function, immunological profiles, and the gut barrier function. Therefore, P. pentosaceus CECT 8330 may serve as a promising probiotic to ameliorate intestinal inflammation. The online version contains supplementary material available at 10.1186/s12967-022-03235-8.
登录
查看更多内容
影响因子:
3.9
作者:
Cui G;Yuan A
通讯作者:
Yuan A
影响因子:
32.4
作者:
Dorrestein PC;Mazmanian SK;Knight R
通讯作者:
Knight R
影响因子:
3.1
作者:
Alizadeh, Arash;Akbari, Peyman;Garssen, Johan;Fink-Gremmels, Johanna;Braber, Saskia
通讯作者:
Braber, Saskia
影响因子:
24.5
作者:
Kruis, W;Fric, P;Schulze, J
通讯作者:
Schulze, J
影响因子:
2.4
作者:
Bosch, M.;Rodriguez, M.;Cune, J.
通讯作者:
Cune, J.